Back to Search
Start Over
Targeted Delivery of Nanocarrier-Conjugated Doxorubicin to Widen the Therapeutic Window of the Most Active Drug in Lymphoma Therapeutics
- Source :
- Blood; November 2019, Vol. 134 Issue: Supplement 1 p4061-4061, 1p
- Publication Year :
- 2019
-
Abstract
- No relevant conflicts of interest to declare.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 134
- Issue :
- Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs53603465
- Full Text :
- https://doi.org/10.1182/blood-2019-122599